Anthony Fauci
Anthony Fauci
Anthony Stephen "Tony" Fauciis an American immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases...
NationalityAmerican
ProfessionScientist
Date of Birth24 December 1940
CountryUnited States of America
ebola today way
Today we know the best way to prevent the spread of Ebola infection is through public health measures.
ebola vaccines viruses
The launch of phase 1 Ebola vaccine studies is a first step in developing a vaccine that could be licensed and used in the field to protect not only the front line health care workers but also those living in areas where Ebola virus exists.
grateful ebola two
We are grateful to the Liberian people who volunteered for this important clinical trial and encouraged by the study results seen with the two investigational Ebola vaccine candidates,
ebola outbreaks feels
We feel confident that there won't be an outbreak.
ebola people facts
We feel confident that there won't be an outbreak. The people who were around the patient are now being identified and traced by the CDC and by the state health authorities. ... you get people, you identify them, and you observe and monitor them daily to determine if they develop symptoms If they do, then you put them under isolation to determine if, in fact, they are infected. And if you do that properly, you can shut down any outbreak.
came diminished hidden levels pool three virus weeks within
Even in individuals in which we diminished the pool of the reservoir, the hidden reservoir, to levels that were essentially non-detectable ... the virus came right back within two to three weeks in essentially everyone.
available currently eliminate eradicate given virus
It does tell us is that given the currently available regimens that we have of anti-viral drugs that we are not going to eliminate or eradicate the virus from individuals,
true
We have to see if it is true and if we can do anything about it,
came fact hoped line percent response
We hoped to see a 75 percent response rate, but the fact it came in at 50 percent is not way out of line for our expectations.
course early
We now know that these reservoirs are established very early in the course of infection.
albeit good high immune news spur vaccine
We have a vaccine we know can spur an immune response, albeit at very high doses. We're going in the right direction. The sobering news is we have a long way to go. So it's muted good news.
alter blunt burst course early enormous initial prevent production virus
Vaccines, if they can blunt that initial, enormous burst of virus production early on, even if it doesn't prevent initial infection, may dramatically alter the course of infection,
direct elicit factor guarantee identify particular protecting response vaccine
If we could identify what that factor is -- and there's no guarantee we will, but if we can -- then one could direct your vaccine to elicit a response of that particular factor that is protecting them.
both private resulted today vaccines
Many vaccines in use today resulted from both government-sponsored and private research.